Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Biotrinine® may be an effective treatment for chronic hair loss.

Essential oils in cosmetics can offer benefits but may cause allergies and should be used carefully.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Mackerel-derived fermented fish oil helps hair grow by activating growth pathways and increasing cell proliferation.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

SCD1 is important for hair growth by keeping the connection in skin cells where hair stem cells live stable.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The scalp's microorganisms significantly affect hair health and disease.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.